Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM
← catalyst calendarSponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
Phase 4
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
633actual
Sites
35
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-03-15 | actual | When the study began enrolling |
| Primary completion | 2025-06-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-06-30 | actual | The whole study's end, after follow-up |
| First posted | 2024-03-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-10-31 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Type 2 Diabetes Mellitus (T2DM)
Interventions
- Drug: Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets — also filed as FDC Regimen of Dapagliflozin/Metformin XR
- Drug: Dapagliflozin tablets and Metformin HCl extended-release tablets — also filed as Co-administered Dual Therapy
Primary outcome
what the primary-completion date above is the date OFChange in HbA1c from baseline
measured 24 weeks
Publications
- PMID 27574406 — cited as background
- PMID 22494018 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed